| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |